Ziopharm Oncology Inc. announced positive data updates supporting survival benefit and the underlying immune system mechanism for Ad-RTS-hIL-12 plus veledimex, the company’s controlled human interleukin-12 gene therapy candidate for brain cancer, at the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology.
Cheng-Chia “Fred” Wu, assistant professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, received a $115,000 extended scholar grant from St. Baldrick’s to support focused ultrasound research for the treatment of diffuse midline glioma and diffuse intrinsic pontine glioma.
